The International Trade Commission published notices in the Nov. 6 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The Commerce Department published notices in the Federal Register Nov. 6 on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms or effective dates will be detailed in another ITT article):
The Commerce Department has released the final results of its countervailing duty administrative review on large diameter welded pipe from South Korea (C-580-898). These final results will be used to set final assessments of CVD on importers for subject merchandise entered during calendar year 2022.
On Nov. 5, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Foreign-Trade Zones Board issued the following notices on Nov. 6:
A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website Nov. 4, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
CBP issued the following releases on commercial trade and related matters:
As Donald Trump returns to the White House in January, a short-term spike in import volumes at U.S. ports is inevitable, given the president-elect's strident stance on tariffs, some logistics experts say.
President-elect Donald Trump's love of tariffs was the through line of his campaigns and his first administration, but a consultant and a think tank scholar say that how exactly he will hike duties next year -- on what products, from which countries and how high -- are unknowable.
Maros Sefcovic of Slovakia, the EU’s candidate for trade and economic security commissioner, said this week he would “double down” on defending European industry against “increasingly widespread” unfair practices.